|
|
Volumn 34, Issue 4, 2002, Pages 1083-1085
|
|
Vaccinia virus complement control protein inhibits hyperacute xenorejection
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
UNCLASSIFIED DRUG;
VACCINIA VIRUS COMPLEMENT CONTROL PROTEIN;
VIRUS PROTEIN;
COMPLEMENT CONTROL PROTEIN, VACCINIA VIRUS;
COMPLEMENT-CONTROL PROTEIN, VACCINIA VIRUS;
RECOMBINANT PROTEIN;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
COMPLEMENT INHIBITION;
CONTROLLED STUDY;
DOSE RESPONSE;
DOSE TIME EFFECT RELATION;
DRUG EFFECT;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEART TRANSPLANTATION;
MALE;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN ANALYSIS;
PROTEIN FUNCTION;
PROTEIN PROTEIN INTERACTION;
RAT;
SPECIES COMPARISON;
SPECIES DIFFERENCE;
SURVIVAL TIME;
VACCINIA VIRUS;
XENOGRAFT;
ANIMAL;
BAGG ALBINO MOUSE;
IMMUNOLOGY;
PICHIA;
SPRAGUE DAWLEY RAT;
SURVIVAL RATE;
ANIMAL;
GRAFT REJECTION;
HEART TRANSPLANTATION;
MALE;
MICE;
MICE, INBRED BALB C;
PICHIA;
RATS;
RATS, SPRAGUE-DAWLEY;
RECOMBINANT PROTEINS;
SUPPORT, NON-U.S. GOV'T;
SURVIVAL RATE;
TRANSPLANTATION, HETEROLOGOUS;
VACCINIA VIRUS;
VIRAL PROTEINS;
ANIMALS;
|
|
EID: 0035998985
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)02805-1 Document Type: Article |
|
Times cited : (13)
|
|
References (12)
|
